Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors

This publication has 13 references indexed in Scilit:

• Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors
  Journal of Medicinal Chemistry, 2010
• The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
  Pulmonary Pharmacology & Therapeutics, 2010
• PDE4 inhibitors: a review of current developments (2005 – 2009)
  Expert Opinion on Therapeutic Patents, 2009
• Global strategy for asthma management and prevention: GINA executive summary
  European Respiratory Journal, 2007
• Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
  Nature Reviews Endocrinology, 2005
• Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
  Structure, 2004
• Drug Treatment of Intermittent Claudication
  Drugs, 2004
• A convenient synthesis for some new pyrido[3′,2′:4,5]thieno‐[3,2‐d]pyrimidine derivatives with potential biological activity
  Journal of Heterocyclic Chemistry, 1992
• Regioselective conversion of cycloalkanones to vinyl bromides with 1,2-functionality transposition. A general stratagem
  The Journal of Organic Chemistry, 1991
• Über die Reaktion von 6‐Amino‐thiopyranthionen‐(2) mit Aminen
  Journal für Praktische Chemie, 1973